Enhanced Recovery After Intensive Care (ERIC)

NCT03671447 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1463

Last updated 2022-05-04

No results posted yet for this study

Summary

The primary objective of the multi-center stepped-wedge cluster-randomized controlled trial ERIC is to evaluate the effects of a multi-component telemedicine-based intervention delivered by the ICU on the adherence to quality indicators (QI) in intensive care medicine compared to usual care.

Critically ill patients treated on the interventional condition receive daily tele-medical rounds during their ICU stay.

Further secondary objectives are to demonstrate whether the intervention improves patient outcomes 3 and 6 months post ICU discharge, compared to usual care.

Conditions

  • Critical Illness

Interventions

OTHER

ICU Usual Care

The control condition delivered at ICU is usual care.

BEHAVIORAL

Tele-ICU

The experimental complex intervention ERIC consists of daily tele-medicine based rounds at ICU. Tele-ICU is implemented after a blended learning program for ICU staff which will be completed prior to the site's crossover.

Sponsors & Collaborators

  • Innovationsausschuss beim Gemeinsamen Bundesausschuss (G-BA), Berlin, Germany

    collaborator UNKNOWN
  • Fraunhofer-Institut für Offene Kommunikationssysteme FOKUS, Berlin, Germany

    collaborator UNKNOWN
  • BARMER

    collaborator OTHER
  • Klinik Ernst von Bergmann Bad Belzig gGmbH, Bad Belzig, Germany

    collaborator UNKNOWN
  • Technische Universität Berlin

    collaborator OTHER
  • Ludwig-Maximilians - University of Munich

    collaborator OTHER
  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Claudia Spies, MD, Prof. · Department of Anesthesiolgy and Operative Intensive Care Medicine CCM/CVK, Charité - Universitätsmedizin Berlin

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-04
Primary Completion
2020-04-15
Completion
2020-11-17

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03671447 on ClinicalTrials.gov